GERN Competitors & Alternatives
Compare Geron Corporation with similar stocks in the same industry
Biotechnology
GERN
Main Stock$1.36
Tradestie Score
53
Market Cap
$899.60M
Revenue Growth
0.3%
Analyst Upside
+150.0%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SEPN
Septerna, Inc. Common Stock
|
$34.00
|
$847.12M | - | 50 | Compare |
|
XNCR
Xencor, Inc.
|
$15.00
|
$843.75M | - | 59 | Compare |
|
GHRS
GH Research PLC Ordinary Shares
|
$27.01
|
$841.74M | - | 58 | Compare |
|
KOD
Kodiak Sciences Inc Common Stock
|
$38.54
|
$832.47M | - | 57 | Compare |
|
URGN
UroGen Pharma Ltd. Ordinary Shares
|
$38.02
|
$824.20M | - | 59 | Compare |
|
IVA
Inventiva S.A. American Depository Shares
|
$3.91
|
$821.84M | - | 59 | Compare |
|
MBX
MBX Biosciences, Inc. Common Stock
|
$57.80
|
$800.41M | - | 53 | Compare |
|
IOVA
Iovance Biotherapeutics, Inc. Common Stock
|
$4.31
|
$799.70M | - | 58 | Compare |
|
KURA
Kura Oncology, Inc.
|
$11.10
|
$798.53M | - | 62 | Compare |
|
VIR
Vir Biotechnology, Inc. Common Stock
|
$10.04
|
$791.82M | - | 57 | Compare |
More GERN Analysis
Data updated: Jul 05, 2026 | Industry: Biotechnology (SIC 2834)
234 stocks in this industry